Treatment of depression with ketamine does not change plasma levels of brain-derived neurotrophic factor or vascular endothelial growth factor is a research paper published in Journal of Affective Disorders (2020). On theSindex it has a DataRank of 0.477. It has been cited 23 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.477
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →BLRD VA
Grant: I01 BX003631
Intramural NIH HHS
Grant: ZIA MH002857
NIMH NIH HHS
Grant: R01 MH107615
NIAID NIH HHS
Grant: R21 AI145211
BLRD VA
Grant: I01 BX004062
National Institutes of Health
Grant: 5R01MH107615-05
Therapeutic Efficacy of Ketamine Metabolites for Depression Treatment
National Institutes of Health
Grant: 1ZIAMH002857-06
Glutamatergic Modulators for Rapid & Sustained Antidepressant Effect
National Institutes of Health
Grant: 5I01BX004062-02
Hydroxynorketamine for the Treatment of PTSD and Anhedonia
FWCI
2.16
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals